Maintaining systolic blood pressure consistently below 130 mmHg could help decrease the risk for new-onset diabetes in the ...

Investigators report findings from an analysis of 7836 robotic-assisted radical cystectomies performed from 2010 to 2021.

Cretostimogene is an oncolytic immunotherapy with dual mechanism of action: viral replication leading to tumor lysis and release of granulocyte-macrophage colony stimulating factor.

A trial tested MRI and microultrasonography guided biopsy separately and in combination for the detection of clinically significant prostate cancer.

The presence of residual tumor cells in the trigone and urethra after robot-assisted radical cystectomy (RARC) is associated with a higher tumor stage, positive margins, and cancer recurrence compared ...

Radiographic disappearance of metastases could be a surrogate marker for outcomes among patients treated for metastatic ...

To mitigate the influence of selection bias, investigators matched patients undergoing active surveillance and partial nephrectomy for small renal masses by their risk of dying of noncancer causes.

A patient-reported outcomes trial used the ICIQ-S to compare patient experiences and satisfaction after ureteroscopy with placement of a silicone or polyurethane stent.

More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...

Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.

The FDA has approved Imfinzi® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with MIBC.

Although the role of radiation therapy is well established in this setting, the role of radical prostatectomy in treating men with de novo oligometastatic prostate cancer has not been well defined.